...
首页> 外文期刊>Calcified Tissue International >Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR
【24h】

Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR

机译:通过竞争性RT-PCR定量纯化的人破骨细胞中溶酶体半胱氨酸蛋白酶的表达水平

获取原文
获取原文并翻译 | 示例
           

摘要

Cathepsin K is a lysosomal cysteine proteinase (LCP) predominantly expressed in osteoclasts. This study was conducted to evaluate the improtance of human cathepsin K for osteoclastic bone resorption relative to that of other LCPs. To accomplish this, we quantitatively determined the expression levels of major LCPs (cathepsins B, K, L, and S) in human osteoclastic cells by using competitive RT-PCR. Giant cell tumor of bone (GCT) was used as a source of human osteoclastic cells, since the tissue was shown to contain a large number of cells satisfying the criteria for typical osteoclasts. The involvement of LCPs in the bone-resorption process by the GCT cells was confirmed by showing thattrans-epoxysucciny-l-leucylamido-(4-guanidino) butane (E-64), a nonselective cysteine proteinase inhibitor, exerted an inhibitory effect on the pit formation. We isolated osteoclast-like cells (OLCs) positive for tartrate-resistant acid phosphatase (TRAP) and cathepsin K from the GCT tissue to a degree of almost 95% purity. In these cells, the expression of cathepsin K was shown to be approximately 20-, 130-, and 410-fold stronger than that of cathepsins B, L, and S, respectively. A similar result was obtained when human bone marrow cells in culture were used as another source of OLCs. Further, we found that cathepsin K was expressed in OLCs far more strongly than in several human nonosteoclastic cells including osteoblastic cell lines. The abundant and selective expression of cathepsin K in OLCs relative to that of other LCPs suggests that cathepsin K is mainly responsible for osteoclastic degradation of human bone matrix.
机译:组织蛋白酶K是主要在破骨细胞中表达的溶酶体半胱氨酸蛋白酶(LCP)。进行这项研究以评估相对于其他LCP而言,人组织蛋白酶K对于破骨细胞骨吸收的重要作用。为此,我们使用竞争性RT-PCR定量测定了人破骨细胞中主要LCP(组织蛋白酶B,K,L和S)的表达水平。骨巨细胞瘤(GCT)被用作人类破骨细胞的来源,因为显示该组织含有大量满足典型破骨细胞标准的细胞。 LCP参与了GCT细胞的骨吸收过程,方法是证明非选择性半胱氨酸蛋白酶抑制剂反式环氧琥珀-1-亮氨酰氨基-(4-胍基)丁烷(E-64)对GCP细胞具有抑制作用。坑的形成。我们从GCT组织中分离出抗酒石酸酸性磷酸酶(TRAP)和组织蛋白酶K阳性的破骨细胞样细胞(OLC),纯度接近95%。在这些细胞中,组织蛋白酶K的表达分别比组织蛋白酶B,L和S强20倍,130倍和410倍。当将培养的人骨髓细胞用作OLC的另一来源时,获得了相似的结果。此外,我们发现组织蛋白酶K在OLC中的表达远强于几种人类非破骨细胞,包括成骨细胞系。相对于其他LCP,组织蛋白酶K在OLC中的丰富且选择性的表达表明,组织蛋白酶K主要负责人骨基质的破骨细胞降解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号